Cantor Fitzgerald’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-50,205
| Closed | -$147K | – | 297 |
|
|
2024
Q2 | $147K | Sell |
50,205
-25,000
| -33% | -$73K | 0.03% | 139 |
|
|
2024
Q1 | $240K | Buy |
75,205
+25,000
| +50% | +$79.8K | 0.06% | 128 |
|
|
2023
Q4 | $169K | Buy |
+50,205
| New | +$169K | 0.03% | 142 |
|
|
2022
Q4 | – | Sell |
-45,205
| Closed | -$160K | – | 780 |
|
|
2022
Q3 | $160K | Hold |
45,205
| – | – | ﹤0.01% | 613 |
|
|
2022
Q2 | $117K | Buy |
45,205
+15,000
| +50% | +$38.8K | ﹤0.01% | 667 |
|
|
2022
Q1 | $135K | Buy |
30,205
+5,000
| +20% | +$22.3K | 0.01% | 274 |
|
|
2021
Q4 | $172K | Buy |
+25,205
| New | +$172K | 0.01% | 271 |
|